Interomex Biopharmaceuticals

Yeast-based repressed transcription activator (RTA) platform to identify inhibitors of protein-protein interactions

placeVancouver, British Columbia, Canada calendar_todayFounded 1999 language interomex.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace dormant.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon